Displaying items by tag: department of pathology

Class of 2017 option 2Chemistry and philosophy classes, a neuro-oncology lab, hospital volunteer work, and the TKE fraternity were all UAB steppingstones for the first-generation American and Florence High School graduate.
UAB’s School of Medicine will host The Alzheimer’s Foundation of America’s National Educating America Tour at UAB to discuss best practices for caregiving, current research efforts and resources for lives affected by Alzheimer’s.
Failure of hormone deprivation therapy used to slow prostate cancer in patients leads to castration-resistant prostate cancer, a lethal form of advanced disease with limited treatment options. Endostatin, used in combination therapy, may help delay onset of castration-resistant disease.
Tina Simpson, M.D., and Marisa B. Marques, M.D., have been recognized by the American Medical Women’s Association for going above and beyond to guide medical students, residents and fellows.
Abnormal antibody production that allows inflammation leading to AIDS is detected by analysis of antibodies in gut fluid of HIV-1-infected people.
The clinical lab in Spain Tower analyzes up to 5,000 tubes of blood each night, providing vital data for caregivers and patients in the nation’s third-largest public hospital.
AEIVA will present a free screening of the film "Side Effects" alongside a tour of the exhibition "Beverly Fishman: Another Day in Paradise," at 6:45 p.m. March 2. The film and exhibition are free and open to the public.
Kids often acquire S. mutans, a cavity-causing bacterium from nonfamily members, researchers report at the American Society for Microbiology annual meeting.
A quality-control checkpoint in pre-B cells restricts the range of antibodies produced by mature B cells, and manipulation of the checkpoint could make vaccines more potent.
This competitive award recognizes outstanding achievements and contributions to VA research and provides five years of salary support.
The new chair named to lead UAB’s Department of Pathology has a strong background in personalized medicine, clinical care and basic science research.
UAB researchers will enroll patients for prospective studies on pathogenesis of a potentially fatal blood clot disorder with a $2.5 million NIH grant.
The challenge is to stifle the binding of inhibitory antibodies but retain activity of a blood enzyme.
UAB pathologist also leads a trainee in producing software to improve the quality and efficiency of perinatal autopsies.
A UAB scientist has received a prestigious international award for contributions to biobanking.
UAB discovery gives better understanding of and potential therapies for septic shock and reperfusion injuries.
Page 7 of 9